Recalls — last 90 days

Philips has identified instances where X-ray imaging may not be initiated or may occur intermittently when using the wired foot switch.

Philips has identified instances where X-ray imaging may not be initiated or may occur intermittently when using the wired foot switch.

Philips has identified instances where X-ray imaging may not be initiated or may occur intermittently when using the wired foot switch.

Philips has identified instances where X-ray imaging may not be initiated or may occur intermittently when using the wired foot switch.

Philips has identified instances where X-ray imaging may not be initiated or may occur intermittently when using the wired foot switch.

Philips has identified instances where X-ray imaging may not be initiated or may occur intermittently when using the wired foot switch.

Philips has identified instances where X-ray imaging may not be initiated or may occur intermittently when using the wired foot switch.

Philips has identified instances where X-ray imaging may not be initiated or may occur intermittently when using the wired foot switch.

In certain situations, following a system reboot, one or more modules may have become unreachable via the remote connectivity interface. When this occurred, there was potential for delays in plate retrieval from the incubator while connectivity was restored. This issue was intermittent and did not affect test results, performance of the assay, or sample integrity.

A potential for depressed results for Atellica CH A1c_E when processing Atellica CH RCRP on the same analyzer. Customers processing A1c_E and RCRP on separate analyzers are not impacted by the recall. The frequency and magnitude of the negative bias and imprecision increase over time and are not consistent with the assay Instructions For Use (IFU). When this issue is present, Quality Control (QC) results demonstrate a negative trend and increased imprecision. The clinical impact of a negative (A1c_E) bias may lead to a delay in diagnosis for diabetes or lead to less-than-optimal treatment for existing diabetes.

Due to a radiotherapy medical system software defect, when performing angular roll corrections followed by a repeat localization, the roll corrections applied in the initial localization scan are not carried through to treatment delivery leading to the treatment plan dose being delivered to the incorrect location, potentially a displacement of 5mm or higher, with a 10% to 20% underdose.

Due to firm distributing a nonconforming product that supposed to be scrapped and not for human use.

Due to firm distributing a nonconforming product that supposed to be scrapped and not for human use.

In some situations, the Obstruction Alarm does not trigger within the timeframe dictated by the relevant standards and may take up to four breaths.

In some situations, the Obstruction Alarm does not trigger within the timeframe dictated by the relevant standards and may take up to four breaths.

In some situations, the Obstruction Alarm does not trigger within the timeframe dictated by the relevant standards and may take up to four breaths.

In some situations, the Obstruction Alarm does not trigger within the timeframe dictated by the relevant standards and may take up to four breaths.

Urgent Medical Device Correction for the Volara system single-patient use circuit due to the potential that patients or caregivers may be unaware of a possible decrease in oxygen levels (oxygen desaturation), or potential lung tissue injury from overexpansion (barotrauma) when the Volara device is used in the home care environment. This correction is providing the home caregiver specific instructions for use.

Potential that the "Purge System Blocked" alarm display on the Automated Impella Controller (AIC) could be delayed when using first generation Impella 5.5 (0550-0008*) pumps.

Increased risk of purge leaks with Generation 1 purge cassettes.

Product is potentially under-processed.

Product is potentially under-processed.

Product contains undeclared milk.

Undeclared milk.

Undeclared sulfites.

Products contain cyclamates (banned sweetener)

Products contain cyclamates (banned sweetener)

Products contain cyclamates (banned sweetener)

Salmonella spp. identified in finished product testing

Foreign Object (Glass)